A precise and delineated description of endogenous oxytocin involvement in human insulin secretion, lipid metabolism, thermogenesis, and musculoskeletal function is crucially needed to form an in-depth understanding of the potential effects of oxytocin treatment on obesity-associated co-morbidities. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.